FDA Adverse Event Injury Summary report: N

SKINVIVE BY JUVEDERM XC 2X1 ML

MDR report key: 18043994 · Received October 31, 2023

Report

Report Number
3005113652-2023-00862
Event Type
Injury
Date Received
October 31, 2023
Date of Event
October 18, 2023
Report Date
February 2, 2024
Manufacturer
ALLERGAN (PRINGY)
Product Code
LMH
UDI-DI
10840228300066
PMA / PMN Number
P110033
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CLARIFICATION TO SECTION C. SUSPECT PRODUCT: LOT NUMBER 963/3. CONTINUED H.6. INVESTIGATION CODE: B15, B17, B20. FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED. IF ANY NEW, CHANGED OR CORRECTED INFORMATION IS NOTED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Additional Manufacturer Narrative · 0

ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: A2, A6, B5, B7, E1, H6, H8.

Additional Manufacturer Narrative · 0

CORRECTION TO G.3.: AWARE DATE WAS SENT AS 19/OCT/2023 IN THE LAST MEDWATCH SUBMISSION. HOWEVER, THE CORRECT AWARE DATE SHOULD BE 18/JAN/2024.

Additional Manufacturer Narrative · 0

ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: H6.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED A PATIENT WAS INJECTED WITH 1ML OF SKINVIVE¿ BY JUVÉDERM® INTO EACH CHEEK AND EXPERIENCED A "VO". THE NEXT DAY, PATIENT RETURNED TO THE PRACTICE WITH NO CAP REFILL RATE AND BLANCHING. HYLENEX WAS ADMINISTERED TWICE. EVENT STATUS UNKNOWN.

Description of Event or Problem · 0

ADDITIONAL DETAILS RECEIVED NOTING THAT THE HYLENEX INJECTIONS OCCURRED THE DAY EVENT STARTED AND NEXT DAY. PATIENT ALSO RECEIVED MASSAGE, WARM COMPRESS, ASPIRIN, AND NITRO PASTE ON THESE DATES. EVENT RESOLVED.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED A PATIENT WAS INJECTED WITH 1ML OF SKINVIVE¿ BY JUVÉDERM® INTO EACH CHEEK AND EXPERIENCED A "VO". THE NEXT DAY, PATIENT RETURNED TO THE PRACTICE WITH NO CAP REFILL RATE AND BLANCHING. HYLENEX WAS ADMINISTERED TWICE. EVENT STATUS UNKNOWN. ADDITIONAL DETAILS RECEIVED NOTING THAT THE HYLENEX INJECTIONS OCCURRED THE DAY EVENT STARTED AND NEXT DAY. PATIENT ALSO RECEIVED MASSAGE, WARM COMPRESS, ASPIRIN, AND NITRO PASTE ON THESE DATES. EVENT RESOLVED.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED A PATIENT WAS INJECTED WITH 1ML OF SKINVIVE¿ BY JUVÉDERM® INTO EACH CHEEK AND EXPERIENCED A "VO". THE NEXT DAY, PATIENT RETURNED TO THE PRACTICE WITH NO CAP REFILL RATE AND BLANCHING. HYLENEX WAS ADMINISTERED TWICE. EVENT STATUS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2091548 SKINVIVE BY JUVEDERM XC 2X1 ML IMPLANT, DERMAL, FOR AESTHETIC USE LMH ALLERGAN (PRINGY) 1000524563 10840228300066

Patients

Seq Age Sex Outcome Treatment
1 41 YR Female Required Intervention| O